Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. EDUCATION PROGRAMMES FOR PERSONS WITH TYPE 1 DIABETES USING AN INSULIN PUMP: A SYSTEMATIC REVIEW

    Research output: Contribution to journalReviewResearchpeer-review

  2. Treatment of modifiable risk factors for foot ulceration in persons with diabetes: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update)

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Glucose homeostasis in statin users-The LIFESTAT study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Oral insulin does not alter gut microbiota composition of NOD mice

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Hemoglobin A1c-levels and subsequent risk of depression in individuals with and without diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases

    Research output: Contribution to journalReviewResearchpeer-review

  4. Discontinuation of diabetes medication in the 10 years before death: a nationwide register-based study: 21-25 September 2020.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  5. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
BACKGROUND: The cardiovascular safety, including risk of myocardial infarction (MI), of individual sulfonylureas (SUs) may differ. It remains uncertain whether treatment with individual SUs influences prognosis following MI. METHODS: We conducted a nationwide population-based follow-up study among all Danish patients hospitalized with first-time MI from 1996 to 2004. From the national health databases, we identified 3930 MI patients who used SUs at the time of admission. We computed mortality rates and rates of MI and heart failure readmission according to type of SU and used Cox's proportional hazards regression analysis to compute hazard ratios (HRs) as estimates of relative risk controlling for differences in prognostic covariates. RESULTS: The 30-day and 1-year mortality after MI among SU users was 22.0% and 35.3%, respectively. We found no substantial differences in 30-day and 1-year mortality among users of different SUs. Use of gliclazide in monotherapy showed a trend towards lower mortality; adjusted HR of 1-year mortality 0.70 (95% CI: 0.48-1.00). Users of the different SUs appeared to have similar risks of new MI and heart failure following MI. CONCLUSIONS: The prognosis after MI was not substantially influenced by the choice of SU.
Original languageEnglish
JournalDiabetes - Metabolism: Research and Reviews (Print Edition)
Volume25
Issue number6
Pages (from-to)515-522
Number of pages8
ISSN1520-7552
DOIs
Publication statusPublished - 2009

ID: 64965469